"","Gene.ID","Freq","mean.LFC","sd.LFC","Uniprot","HGNC","fxn","Go.terms","Go.fxns","gene.length"
"1","PGEN_.00g003940",3,3.88074276587087,0.405783714180824,"Q2PFX5","RGN_MACFA","Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)","GO:0004341; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0030234; GO:0032781; GO:0050848","cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]",6291
"2","PGEN_.00g027970",3,4.54657127977815,1.04939869925553,NA,NA,NA,NA,NA,9095
"3","PGEN_.00g057310",3,5.77581058743543,1.03744880234943,"P82968","MCPI_MELCP","Four-domain proteases inhibitor (McaPI)","GO:0004867","serine-type endopeptidase inhibitor activity [GO:0004867]",11964
"4","PGEN_.00g092270",3,-7.49770288334468,1.52353438626513,"Q6YHK3","CD109_HUMAN","CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)","GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675","anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]",54935
"5","PGEN_.00g130390",3,-9.16438513788301,5.69156866520284,NA,NA,NA,NA,NA,1989
"6","PGEN_.00g133710",3,5.21140809724057,1.47919895415671,NA,NA,NA,NA,NA,8603
"7","PGEN_.00g158570",3,5.21884760557433,1.56018964363962,NA,NA,NA,NA,NA,3532
"8","PGEN_.00g162900",3,-11.434806539728,4.37892239096208,NA,NA,NA,NA,NA,1829
"9","PGEN_.00g169480",3,4.82677665063601,1.17696877290544,"Q13231","CHIT1_HUMAN","Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]",23699
"10","PGEN_.00g188250",3,4.44739491938089,1.40678799585333,"P15941","MUC1_HUMAN","Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]","GO:0000790; GO:0000978; GO:0002039; GO:0002223; GO:0003712; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016266; GO:0016324; GO:0019221; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]",89020
"11","PGEN_.00g199810",3,4.53193843774125,1.63347878459727,"P28840","NEC1_RAT","Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)","GO:0004175; GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0009749; GO:0010035; GO:0010157; GO:0014070; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030141; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042493; GO:0042802; GO:0043005; GO:0043025; GO:0043043; GO:0043204; GO:0043278; GO:0043434; GO:0043559; GO:0043679; GO:0044877; GO:0048471; GO:0048678; GO:0050714; GO:0051087; GO:0051384; GO:0051592; GO:0070542; GO:0070555","axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]",29363
"12","PGEN_.00g211250",3,4.07194498452085,1.04110198048857,"Q9BXJ4","C1QT3_HUMAN","Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)","GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223","cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]",20121
"13","PGEN_.00g266130",3,-14.0945396446971,5.80365815954766,"Q5XWD5","IF_CANLF","Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor) (IF) (INF) (Pancreatic intrinsic factor)","GO:0005576; GO:0006824; GO:0015889; GO:0031419","extracellular region [GO:0005576]; cobalamin binding [GO:0031419]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]",12468
"14","PGEN_.00g272710",3,4.51871888720993,1.55747842201082,"B3EWZ3","CADN_ACRMI","Coadhesin (Fragment)","GO:0016021","integral component of membrane [GO:0016021]",27585
"15","PGEN_.00g279590",3,5.53680602078569,2.52276710581301,"Q8SPI0","APOD_MACFA","Apolipoprotein D (Apo-D) (ApoD)","GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405","cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]",9989
"16","PGEN_.00g291230",3,-11.8820367150307,6.57498037540877,NA,NA,NA,NA,NA,967
"17","PGEN_.00g295020",3,-12.8291030403163,5.17885854046399,NA,NA,NA,NA,NA,4588
"18","PGEN_.00g313880",3,4.9686231480778,1.30790850217743,NA,NA,NA,NA,NA,6012
"19","PGEN_.00g333460",3,-9.96295698644774,3.50847574337648,NA,NA,NA,NA,NA,3336
"20","PGEN_.00g340250",3,-9.20703223579492,2.77984724213753,NA,NA,NA,NA,NA,20567
"21","PGEN_.00g348220",3,4.38677682674732,1.79196422549102,"Q9ES87","PRSS8_RAT","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0042493; GO:0043434; GO:0045121; GO:0046658; GO:0051385; GO:0070633; GO:1902307","anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; response to drug [GO:0042493]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; transepithelial transport [GO:0070633]",29240
"22","PGEN_.00g348570",3,4.37924889257037,1.73581775162642,"Q9ES87","PRSS8_RAT","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0042493; GO:0043434; GO:0045121; GO:0046658; GO:0051385; GO:0070633; GO:1902307","anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; response to drug [GO:0042493]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; transepithelial transport [GO:0070633]",29227
